From Alchemy to IPO: The Business of Biotechnology

From Alchemy to IPO: The Business of Biotechnology

From Alchemy to IPO: The Business of Biotechnology

From Alchemy to IPO: The Business of Biotechnology

Synopsis

Written by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry -- biotechnology -- that's on the verge of living up to its monumental promise to change the world as we know it.

Excerpt

As we head into the new millennium and into biotech's third decade, the industry is undergoing a resurgence of energy. The AMEX Biotech Stock Index performance has caught up with the Standard & Poor's 500 Index performance for the first time since 1993 and shows no signs of stopping. The top 100 public companies represent more than $200 billion in market capitalization. Biotechnology is poised to provide another incredible run for investors.

Even more important, there are 65 new drugs on the market that came from biotech labs and another 140 in final stages of the regulatory process. Every day, the industry labs generate more information about how our bodies work, in sickness and in health, down to the single-molecule level. For the first time in history, it is possible to design new treatments for diseases such as Alzheimer's disease, Lou Gehrig's disease, breast and prostate cancer, and heart disease--and aim those drugs directly at the molecular causes of the disease. More effective drugs, with fewer nasty side effects, will be possible because of biotechnology.

But wait--there's more! Most of us think of biotech as medicine or genetically engineered crops. In the next 30 years, biotechnology may make it possible for humans to reach the stars and to change the environment on other planets to become more hospitable to human life. Computers based on the human brain, spacecraft using cell-like signaling pathways and genetic information encoding structural and functional molecules to evolve in new environments, transgenic crops able to generate enough food in spacecraft environments to feed a crew, drug discovery tools rapid enough to help astronauts deal with unknown organisms on other planets--all of this is in early stages of development today.

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.